It is possible that more potent GLP-1 drugs, and triple-receptor agonists will achieve a greater degree of weight loss and extend the benefit to lower risk people in the future
Gonzalez- Rivas PA, Chambers M, Liu J
On the other hand, metformin-treated mice displayed a slight decrease in body weight, fat mass, and circulating glucose, insulin, and leptin levels, which was associated with a modest reduction of HOMA-IR index and a drop in daily food intake (Fig
The GLP-1 system regulates appetite through multiple pathways in your brain, pancreas, and gut
Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder